Here's Why We're Not Too Worried About Poltreg's (WSE:PTG) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Polish (WIG) Biotech Industry Analysis
UpdatedJun 28, 2022
DataAggregated Company Financials
Companies14
- 7D-1.3%
- 3M-14.2%
- 1Y-50.7%
- YTD-35.7%
The Biotech is pretty flat in the last 7 days, but BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek has stood out, gaining 5.4%. As for the longer term, the industry has declined 51% in the last year. Looking forward, earnings are forecast to grow by 71% annually.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Tue, 28 Jun 2022 | zł2.3b | zł472.9m | zł66,686.00 | 24.9x |
| Thu, 26 May 2022 | zł2.5b | zł426.5m | zł14.0m | 35x |
| Sat, 23 Apr 2022 | zł2.8b | zł369.1m | -zł37,778,677.00 | 36.1x |
| Mon, 21 Mar 2022 | zł2.8b | zł348.8m | -zł40,884,677.00 | 33.1x |
| Wed, 16 Feb 2022 | zł3.1b | zł348.5m | -zł40,520,361.00 | 51.5x |
| Fri, 14 Jan 2022 | zł3.7b | zł369.9m | -zł24,922,742.00 | 49.5x |
| Sun, 12 Dec 2021 | zł3.7b | zł369.9m | -zł24,922,742.00 | 49.8x |
| Tue, 09 Nov 2021 | zł3.6b | zł368.8m | zł763.7k | 32.8x |
| Thu, 07 Oct 2021 | zł3.5b | zł364.5m | -zł1,455,285.00 | 33.3x |
| Sat, 04 Sep 2021 | zł3.7b | zł362.9m | -zł8,912,285.00 | 38.8x |
| Mon, 02 Aug 2021 | zł3.6b | zł362.9m | -zł8,912,285.00 | 37.4x |
| Thu, 06 May 2021 | zł3.8b | zł373.1m | -zł6,705,220.00 | 122x |
| Sun, 07 Feb 2021 | zł1.6b | zł382.5m | zł56.4m | 110.3x |
| Sat, 31 Oct 2020 | zł2.1b | zł307.0m | -zł7,012,804.00 | 59.4x |
| Tue, 04 Aug 2020 | zł2.5b | zł289.2m | -zł30,736,114.00 | 37.7x |
| Fri, 08 May 2020 | zł851.1m | zł304.1m | -zł149,014,103.00 | 47.7x |
| Mon, 10 Feb 2020 | zł581.0m | zł295.6m | -zł128,943,953.00 | 36.7x |
| Sun, 03 Nov 2019 | zł592.9m | zł300.9m | -zł129,547,264.00 | 28.2x |
| Wed, 07 Aug 2019 | zł1.9b | zł302.3m | -zł201,837,301.00 | 31.6x |
Median PE Ratio
32.3x
Current Industry PE
- Investors are optimistic on the industry, and appear confident in long-term growth rates.
- The industry is trading at a PE ratio of 35kx which is higher than its 3-year average PE of 72.7x.
- The industry's 3-year average PS ratio 6.2x is higher than the industry's current PS ratio of 4.9x.
Past Earnings Growth
- Total earnings for the Biotechnology industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 16% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Polish Biotech compare with similar industries?
| PL Market | 1.63% | |
| Healthcare | 2.76% | |
| Biotech | -1.26% | |
| Biotech | -1.26% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BML BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek | zł3.15 | 2.6% +zł5.2m | -66.8% | PS44x | |
| GMT Genomtec | zł6.08 | 6.5% +zł3.0m | -53.1% | PS237.6x | |
| URT Urteste | zł89.80 | 2.3% +zł2.3m | n/a | n/a | |
| SCS Stem Cells Spin | zł0.37 | 9.4% +zł1.3m | -69.3% | PS50.7x | |
| BER Bioerg Spólka Akcyjna | zł0.16 | 0.3% +zł50.8k | -46.3% | PS3.2x |